Thank you, Paul. Today, there are three ideas that I would like to cover with my comments. First and foremost, I would like to build on Paul’s point of recovering operating performance in our portfolio, specifically with focus on California, permanent crops, while our agriculture was not impacted nearly as much as any as most other industries throughout the COVID pandemic. In 2020, there were some specific crops that were indeed affected by the pandemic. For example, the bar trade had dramatically lower demand for citrus lemon in particular, and we saw that impact in our financial. Also in 2020, there were some trade disruptions that affected our returns. We have seen a strong recovery in those crops in 2021 over 2020, and as reflected in both variable rents as well as the gross margin in the directly operated farms in our portfolio. The second point I would like to address is, our acquisition and disposition activity. During 2021, we made 12 acquisitions totaling $81.2 million and 20 dispositions totaling $73 million, across the board. So this will appear a very, very modest increase in our portfolio size. But specifically, I would like to point out that of the $73 million in dispositions, $21.5 million were to the Opportunity Zone Fund that we manage and therefore those farms that we sold to the Opportunity Zone Fund continue to produce revenue for us through our management fee in OZ fund. And secondly, we have -- in this acquisition and disposition activity that we continue to do at the margin of our portfolio really continues to gradually improve cap rates in those specific farms. Finally, I would like to address another important event for us in 2021, which is the Series B conversion that took place in the fourth quarter. At the beginning of the fourth quarter, it de-levered our balance sheet, it increased our common equity without underwriting discounts, so underwriting fees. It was overall an instrument that gave us great access to capital at the time when common equity was not a viable avenue for us to raise capital. The common equity price -- the common stock price between the time when we issued the Series B and we converted it, increased by 45%, but most importantly, this Series B conversion is creative to AFFO and cash flow in general. And in the fourth quarter of 2021, we just started to see the positive impact of the conversion, which will be of course magnified in the full year of 2022. With that, those were my comments for today, and I will now turn the call over to James to cover some financial highlights, containing our earnings release and supplemental. James?